Control of cell migration: a tumour suppressor function for p53?

被引:106
作者
Roger, L [1 ]
Gadea, G [1 ]
Roux, P [1 ]
机构
[1] CNRS, Ctr Rech & Biochim Macromol, FRE 2593, IFR 24, F-34293 Montpellier 5, France
关键词
cytoskeleton; migration; p53; Rho GTPase; tumour suppressor;
D O I
10.1042/BC20050058
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Much remains to be learned about how cancer cells acquire the property of migration, a prerequisite for invasiveness and metastasis. Loss of p53 functions is assumed to be a crucial step in the development of many types of cancers, leading to dysregulation of cell cycle checkpoint controls and apoptosis. However, emerging evidence shows that the contribution of the tumour suppressor p53 to the control of tumorigenesis is not restricted to its well-known anti-proliferative activities, but is extended to other stages of cancer development, i.e. the modulation of cell migration. This interesting alternative function has been proposed in light of the effect of p53 on specific features of migrating cells, including cell spreading, establishment of cell polarization and the production of protrusions. The effects of p53 on cell motility are largely mediated through the regulation of Rho signalling, thereby controlling actin cytoskeletal organization. These recent studies connect the regulation of proliferation to the control of cell migration and define a new concept of p53 function as a tumour suppressor gene, suggesting that p53 might be involved in tumour invasion and metastasis. This review focuses on emerging data concerning the properties of p53 that contribute to its atypical role in the regulation of cell migration.
引用
收藏
页码:141 / 152
页数:12
相关论文
共 106 条
[1]   Changes in p53 expression in mouse fibroblasts can modify motility and extracellular matrix organization [J].
Alexandrova, A ;
Ivanov, A ;
Chumakov, P ;
Kopnin, B ;
Vasiliev, J .
ONCOGENE, 2000, 19 (50) :5826-5830
[2]   P53 EXPRESSION DURING NORMAL TISSUE REGENERATION IN RESPONSE TO ACUTE CUTANEOUS INJURY IN SWINE [J].
ANTONIADES, HN ;
GALANOPOULOS, T ;
NEVILLEGOLDEN, J ;
KIRITSY, CP ;
LYNCH, SE .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (05) :2206-2214
[3]   Activation and activities of the p53 tumour suppressor protein [J].
Bálint, É ;
Vousden, KH .
BRITISH JOURNAL OF CANCER, 2001, 85 (12) :1813-1823
[4]   RET/PTC1 oncogene signaling in PCCl 3 thyroid cells requires the small GTP-binding protein Rho [J].
Barone, MV ;
Sepe, L ;
Melillo, RM ;
Mineo, A ;
Santelli, G ;
Monaco, C ;
Castellone, MD ;
Tramontano, D ;
Fusco, A ;
Santoro, M .
ONCOGENE, 2001, 20 (48) :6973-6982
[5]   Metastasis genes: A progression puzzle [J].
Bernards, R ;
Weinberg, RA .
NATURE, 2002, 418 (6900) :823-823
[6]   p27Kip1 modulates cell migration through the regulation of RhoA activation [J].
Besson, A ;
Gurian-West, M ;
Schmidt, A ;
Hall, A ;
Roberts, JM .
GENES & DEVELOPMENT, 2004, 18 (08) :862-876
[7]   Regulation of the cytoskeleton: An oncogenic function for CDK inhibitors? [J].
Besson, A ;
Assoian, RK ;
Roberts, JM .
NATURE REVIEWS CANCER, 2004, 4 (12) :948-955
[8]   Activation of Rho is required for ligand-independent oncogenic signaling by a mutant epidermal growth factor receptor [J].
Boerner, JL ;
Danielsen, A ;
McManus, MJ ;
Maihle, NJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (05) :3691-3695
[9]   Rho family GTPases regulate mammary epithelium cell growth and metastasis through distinguishable pathways [J].
Bouzahzah, B ;
Albanese, C ;
Ahmed, F ;
Pixley, F ;
Lisanti, MP ;
Segall, JD ;
Condeelis, J ;
Joyce, D ;
Minden, A ;
Der, CJ ;
Chan, A ;
Symons, M ;
Pestell, RG .
MOLECULAR MEDICINE, 2001, 7 (12) :816-830
[10]  
Buendia MA, 2000, SEMIN CANCER BIOL, V10, P185